See more : Umuthi Healthcare Solutions Plc (UHS.L) Income Statement Analysis – Financial Results
Complete financial analysis of Asahi Kasei Corporation (AHKSY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Asahi Kasei Corporation, a leading company in the Chemicals industry within the Basic Materials sector.
- HEXPOL AB (publ) (HXPLF) Income Statement Analysis – Financial Results
- Magna Terra Minerals Inc. (MTT.V) Income Statement Analysis – Financial Results
- Ameren Illinois Company PFD 4.26% (AILIO) Income Statement Analysis – Financial Results
- Peeti Securities Limited (PEETISEC.BO) Income Statement Analysis – Financial Results
- AeroEdge Co., Ltd. (7409.T) Income Statement Analysis – Financial Results
Asahi Kasei Corporation (AHKSY)
About Asahi Kasei Corporation
Asahi Kasei Corporation manufactures, processes, and sells chemical products in Japan and internationally. The company operates through three segments: Material, Homes, and Health Care. It provides caustic soda, chemical fertilizers, nitric acid, ammonia, acrylonitrile, methyl methacrylate, styrene, adipic acid, hexamethylene diamine, AH salt, propionitrile, sodium cyanide, acetonitrile, methacrylonitrile, cyclohexyl methacrylate, cyclohexanol, cyclohexane, and cyclohexene; polymers; chemical intermediates; additives; membranes and systems; clads and anchors; optical and printing materials; electronic materials; and lithium-ion battery and lead-acid battery separators. The company offers cupro fiber, lining fabric, stretch fiber, spunbond nonwovens, cupro nonwoven fabric, microfiber suede, oil-water separator, multifunctional nonwoven, deodorizing nonwoven, heat-press formable thermoplastic nonwoven, noise suppression sheet, nylon filaments, flame-resistant fiber, honeycomb fabric, cellulose nanobead, ecorise, biocradle, and bemliese products, as well as polymers; synthetic rubber; elastomers; kitchen and household products; cleaners; and packaging products. In addition, the company provides electronic devices; and autoclaved aerated concrete, foundation systems, insulation materials, and structural systems and components. Further, it involved in the construction of homes and apartments; management of rental units and condominiums; brokerage of used homes; remodeling; and mortgage financing, asset management services, and insurance products. Additionally, the company provides pharmaceuticals and diagnostic reagents; dialyzers; therapeutic apheresis; biotherapeutics and plasma derivative filters and equipment, and virus removal filters; leukocyte reduction filters; defibrillators, temperature management systems, and data solutions; and UVC LED products. Asahi Kasei Corporation was founded in 1922 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,784.88B | 2,726.49B | 2,461.32B | 2,106.05B | 2,151.65B | 2,170.40B | 2,042.22B | 1,882.99B | 1,940.91B | 1,986.41B | 1,897.77B | 1,666.64B |
| Cost of Revenue | 1,935.67B | 1,921.72B | 1,664.35B | 1,397.12B | 1,447.88B | 1,454.66B | 1,369.41B | 1,276.17B | 1,334.57B | 1,439.34B | 1,385.70B | 1,239.45B |
| Gross Profit | 849.21B | 804.77B | 796.97B | 708.93B | 703.76B | 715.75B | 672.80B | 606.83B | 606.34B | 547.06B | 512.06B | 427.19B |
| Gross Profit Ratio | 30.49% | 29.52% | 32.38% | 33.66% | 32.71% | 32.98% | 32.94% | 32.23% | 31.24% | 27.54% | 26.98% | 25.63% |
| Research & Development | 106.60B | 105.03B | 98.69B | 89.75B | 90.97B | 90.12B | 85.70B | 79.57B | 81.12B | 75.54B | 71.10B | 71.12B |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 374.68B | 350.06B | 330.58B | 323.23B | 295.14B | 280.05B | 249.03B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.35B | 38.57B | 37.45B | 36.79B | 36.09B | 35.28B | 32.83B |
| SG&A | 601.87B | 571.39B | 495.63B | 447.37B | 435.53B | 416.04B | 388.63B | 368.03B | 360.02B | 331.23B | 315.33B | 281.86B |
| Other Expenses | 0.00 | -7.46B | -1.53B | -216.00M | -6.12B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 708.47B | 676.42B | 594.32B | 537.12B | 526.50B | 506.16B | 474.33B | 447.60B | 441.14B | 390.88B | 349.69B | 345.80B |
| Cost & Expenses | 2,644.13B | 2,598.13B | 2,258.67B | 1,934.24B | 1,974.38B | 1,960.82B | 1,843.74B | 1,723.76B | 1,775.71B | 1,830.22B | 1,735.40B | 1,585.25B |
| Interest Income | 7.68B | 3.90B | 1.36B | 1.90B | 2.77B | 3.09B | 2.08B | 1.43B | 1.42B | 2.26B | 1.49B | 911.00M |
| Interest Expense | 7.45B | 5.91B | 3.64B | 3.21B | 4.02B | 4.37B | 4.59B | 4.44B | 3.61B | 3.06B | 3.38B | 3.34B |
| Depreciation & Amortization | 182.20B | 177.29B | 148.13B | 133.27B | 118.30B | 104.05B | 113.46B | 109.19B | 109.63B | 95.22B | 94.64B | 86.81B |
| EBITDA | 218.49B | 305.00B | 350.78B | 287.39B | 278.25B | 313.63B | 311.94B | 268.42B | 274.84B | 253.15B | 237.99B | 178.77B |
| EBITDA Ratio | 7.85% | 11.19% | 14.25% | 14.49% | 13.74% | 14.45% | 15.27% | 14.26% | 14.16% | 12.74% | 12.54% | 10.73% |
| Operating Income | 140.75B | 128.35B | 202.65B | 171.81B | 177.26B | 209.59B | 198.48B | 159.23B | 165.20B | 157.93B | 143.35B | 91.96B |
| Operating Income Ratio | 5.05% | 4.71% | 8.23% | 8.16% | 8.24% | 9.66% | 9.72% | 8.46% | 8.51% | 7.95% | 7.55% | 5.52% |
| Total Other Income/Expenses | -111.90B | -189.62B | 12.48B | -20.90B | -21.33B | 809.00M | 19.86B | -1.84B | -18.81B | 507.00M | 20.51B | -9.66B |
| Income Before Tax | 28.84B | -61.91B | 215.12B | 150.91B | 155.93B | 210.40B | 218.33B | 157.39B | 146.39B | 158.44B | 163.86B | 82.30B |
| Income Before Tax Ratio | 1.04% | -2.27% | 8.74% | 7.17% | 7.25% | 9.69% | 10.69% | 8.36% | 7.54% | 7.98% | 8.63% | 4.94% |
| Income Tax Expense | -17.49B | 27.46B | 51.29B | 68.81B | 50.21B | 60.58B | 46.14B | 40.72B | 52.98B | 51.54B | 61.77B | 28.40B |
| Net Income | 43.81B | -91.31B | 161.88B | 79.77B | 103.93B | 147.51B | 170.25B | 115.00B | 91.75B | 105.65B | 101.30B | 53.71B |
| Net Income Ratio | 1.57% | -3.35% | 6.58% | 3.79% | 4.83% | 6.80% | 8.34% | 6.11% | 4.73% | 5.32% | 5.34% | 3.22% |
| EPS | 31.60 | -65.84 | 116.68 | 57.49 | 74.85 | 105.66 | 121.93 | 82.34 | 65.69 | 75.62 | 72.48 | 38.43 |
| EPS Diluted | 31.60 | -65.84 | 116.68 | 57.49 | 74.85 | 105.66 | 121.93 | 82.34 | 65.69 | 75.62 | 72.48 | 38.43 |
| Weighted Avg Shares Out | 1.39B | 1.39B | 1.39B | 1.39B | 1.39B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B |
| Weighted Avg Shares Out (Dil) | 1.39B | 1.39B | 1.39B | 1.39B | 1.39B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B | 1.40B |
Asahi Kasei Battery Separator Corporation Breaks Ground on Lithium-ion Battery Separator Plant in the Niagara Region
Asahi Kasei America, Inc. Moves Headquarters to Novi, Michigan
Asahi Kasei Launches New Grade of LASTAN™ Flame-Retardant Nonwoven Fabric
Asahi Kasei establishes the “AKM Co-creation & Technology Center,” a development base to consolidate the organization's functions, in Shin-Yokohama, Japan
Asahi Kasei Medical completes new assembly plant for Planova™ virus removal filters
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion
China Strikes Back At Biden's Tariffs With New Investigation Into Plastics Imports: 6 Stocks Caught In Crossfire
Asahi Kasei starts operation of multi-module hydrogen pilot plant in Kawasaki
Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
Source: https://incomestatements.info
Category: Stock Reports